Cardiac Corrected QT Interval Changes Among Patients Treated for COVID-19 Infection During the Early Phase of the Pandemic

Authors:

Abstract
COVID-19 has resulted in the death of nearly half a million Americans, with few effective treatment options.1-3 At the beginning of the pandemic, hydroxychloroquine and azithromycin were studied and frequently prescribed.4,5 Because both hydroxychloroquine and azithromycin prolong corrected QT interval (QTc) (via IKr or HERG),6,7 QTc interval changes and torsades de pointes (TDP) potential in patients with COVID-19 receiving hydroxychloroquine and/or azithromycin was a focus of multiple single-group studies.8-11

This publication has 39 references indexed in Scilit: